InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment specializes in providing electronic ambulatory infusion devices and accompanying disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy facilities. These devices are crucial for managing various cancers, including colorectal cancer, as well as for pain management and other therapeutic needs. Moreover, the company markets, leases, and rents out a selection of new and pre-owned infusion pumps (both pole-mounted and ambulatory) and other vital durable medical equipment. It also sells consumables essential for treatment. InfuSystem further extends its offerings to include biomedical recertification, maintenance, and repair services for oncology practices and diverse alternative care settings, such as home care and home infusion providers, skilled nursing facilities, pain centers, and hospitals. Additionally, InfuSystem furnishes both local and field-based customer assistance and manages dedicated pump service and repair facilities. The company was founded in 2005 and maintains its corporate headquarters in Rochester Hills, Michigan.
收盘时
US$13.60
+US$0.04 · +0.29%
盘后
US$13.60
US$0.00 · 0.00%
10月12日 16:31 ET
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
82
深度低估
情绪
59
多空交织
风险
50
风险偏高
动量
43
中性
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment specializes in providing electronic ambulatory infusion devices and accompanying disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy facilities. These devices are crucial for managing various cancers, including colorectal cancer, as well as for pain management and other therapeutic needs. Moreover, the company markets, leases, and rents out a selection of new and pre-owned infusion pumps (both pole-mounted and ambulatory) and other vital durable medical equipment. It also sells consumables essential for treatment. InfuSystem further extends its offerings to include biomedical recertification, maintenance, and repair services for oncology practices and diverse alternative care settings, such as home care and home infusion providers, skilled nursing facilities, pain centers, and hospitals. Additionally, InfuSystem furnishes both local and field-based customer assistance and manages dedicated pump service and repair facilities. The company was founded in 2005 and maintains its corporate headquarters in Rochester Hills, Michigan.
日内区间
当前US$13.60
52周区间
当前US$13.60
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 1.43亿 USD | 1.35亿 USD | 1.26亿 USD | 1.1亿 USD | 1.02亿 USD |
| 销货成本 | 6314万 USD | 6445.8万 USD | 6267.6万 USD | 4935.4万 USD | 4384.6万 USD |
| 毛利 | 8029.6万 USD | 7040.3万 USD | 6310.9万 USD | 6056万 USD | 5853.6万 USD |
| 销售、一般及管理费用 | 6745.6万 USD | 6252.1万 USD | 5803.1万 USD | 5641.2万 USD | 5145.4万 USD |
| 营业费用 | 6837.6万 USD | 6351.2万 USD | 5902.1万 USD | 5890.6万 USD | 5571.6万 USD |
| 利息支出 | 129.9万 USD | 177.7万 USD | 217万 USD | 140.2万 USD | 137.7万 USD |
| 折旧和摊销 | 1329.4万 USD | 1249.9万 USD | 1250.8万 USD | 1336万 USD | 1462.5万 USD |
| 营业利润 | 1192万 USD | 689.1万 USD | 408.8万 USD | 165.4万 USD | 282万 USD |
| 净利润 | 662.7万 USD | 234.5万 USD | 87.2万 USD | 1.8万 USD | 142万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化,并非 GoAI 建议。
平均目标
US$15.00
上涨空间 10.29%评级样本有限,仅4项
报告持有此股票敞口的交易所交易基金。
Avantis U.S. Small Cap Value ETFAVUV1094.19万0.04%308.51亿 USD0.25%US$119.94+0.25%
iShares Russell 2000 ETFIWM665.5万0.01%787.4亿 USD0.19%US$277.9-0.37%
Vanguard Morningstar Total Stock Market ETFVTI664.87万0.00%2.3万亿 USD0.03%US$381.57-0.10%
Vanguard Extended Market ETFVXF288.85万0.00%954亿 USD0.05%US$233.52-0.63%
iShares Russell 2000 Growth ETFIWO244.6万0.02%139.17亿 USD0.24%US$353.71-0.86%
Dimensional - US Small Cap ETFDFAS209.43万0.01%338.69亿 USD0.31%US$78.17-0.23%
Dimensional - US Targeted Value ETFDFAT200.82万0.01%301.22亿 USD0.33%US$67.42+0.22%
Vanguard Russell 2000 ETFVTWO134.86万0.01%180亿 USD0.06%US$112.27-0.35%
Avantis U.S. Small Cap Value ETFAVUV
iShares Russell 2000 ETFIWM
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
iShares Russell 2000 Growth ETFIWO
Dimensional - US Small Cap ETFDFAS
Dimensional - US Targeted Value ETFDFAT
Vanguard Russell 2000 ETFVTWOAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。